MyAverix Finance MyAverix Finance

HM · Healthcare

Biotest Aktiengesellschaft (BIO)

Biotechnology

Biotest Aktiengesellschaft (BIO) is listed on HM in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for BIO

P/E ratio
18.00

Biotest Aktiengesellschaft (BIO) — FAQ

What is BIO's P/E ratio?

The price-to-earnings (P/E) ratio for Biotest Aktiengesellschaft (BIO) is 18.00 (data as of 2026-03-22).

Does Biotest Aktiengesellschaft pay a dividend?

Dividend yield is not available in the current snapshot for Biotest Aktiengesellschaft (BIO). Check the MyAverix Finance app for the latest dividend data.

What sector is Biotest Aktiengesellschaft in?

Biotest Aktiengesellschaft (BIO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BIO listed on?

BIO is listed on HM.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play